Search Results - "Viceconti, R."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis by Mossetti, G., Vuotto, P., Rendina, D., Numis, F. G., Viceconti, R., Giordano, F., Cioffi, M., Scopacasa, F., Nunziata, V.

    Published in Journal of internal medicine (01-02-2003)
    “… Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V (Federico II University Medical School, Naples, Italy)…”
    Get full text
    Journal Article
  3. 3

    Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates by Rendina, D, Mossetti, G, Viceconti, R, Sorrentino, M, Nunziata, V

    Published in Calcified tissue international (01-09-2004)
    “…The aim of this study was to evaluate the efficacy and safety of risedronate and pamidronate in 30 patients (mean age = 57.86 +/- 8.90 years) with severe…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Independent Association of Coronary Flow Reserve with Left Ventricular Relaxation and Filling Pressure in Arterial Hypertension by Galderisi, Maurizio, de Simone, Giovanni, D'Errico, Arcangelo, Sidiropulos, Milena, Viceconti, Roberto, Chinali, Marcello, Mondillo, Sergio, de Divitiis, Oreste

    Published in American journal of hypertension (01-09-2008)
    “…Background It has been recognized that “cross-talk” occurs between coronary flow and left ventricular (LV) function. This study tested the hypothesis that…”
    Get full text
    Journal Article
  6. 6

    Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients by Rendina, Domenico, Mossetti, Giuseppe, Viceconti, Roberto, Sorrentino, Mariangela, Castaldo, Rosaria, Manno, Giuseppe, Guadagno, Vincenzo, Strazzullo, Pasquale, Nunziata, Vincenzo

    Published in Urology (Ridgewood, N.J.) (01-10-2004)
    “…To investigate the association between fasting idiopathic hypercalciuria (IHc), defined as IHc in the fasting state associated with normal parathyroid…”
    Get full text
    Journal Article
  7. 7

    Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment by Mossetti, Giuseppe, Rendina, Domenico, De Filippo, Gianpaolo, Viceconti, Roberto, Di Domenico, Gilda, Cioffi, Michele, Postiglione, Loredana, Nunziata, Vincenzo

    Published in Bone (New York, N.Y.) (01-03-2005)
    “…Serum concentrations of interleukin-6 (IL-6), IL-6-soluble receptor (sIL-6R), IL-6 gp130-soluble receptor (sgp130), ligand of receptor activator of nuclear…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis by Rendina, D, De Filippo, G, Viceconti, R, Soscia, E, Sirignano, C, Salvatore, M, Della Monica, M, Scarano, G, Mossetti, G

    Published in Scandinavian journal of rheumatology (01-05-2008)
    “…Primary pachydermoperiostosis (PDP) is a rare syndrome, characterized by digital clubbing, periostosis, and pachydermia. We have evaluated biochemical bone…”
    Get full text
    Journal Article
  10. 10

    Giant cell tumor and Paget's disease of bone in one family: geographic clustering by Rendina, Domenico, Mossetti, Giuseppe, Soscia, Ernesto, Sirignano, Cesare, Insabato, Luigi, Viceconti, Roberto, Ignarra, Rosa, Salvatore, Marco, Nunziata, Vincenzo

    Published in Clinical orthopaedics and related research (01-04-2004)
    “…Giant cell tumor is a rare complication of Paget's disease of bone. Typically, this tumor occurs in the case of polyostotic disease and only in pagetic bones…”
    Get more information
    Journal Article
  11. 11

    Interleukin (IL)-6 and receptor activator of nuclear factor (NF)- B ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis by Rendina, D., De Filippo, G., Viceconti, R., Soscia, E., Sirignano, C., Salvatore, M., Della Monica, M., Scarano, G., Mossetti, G.

    “…Primary pachydermoperiostosis (PDP) is a rare syndrome, characterized by digital clubbing, periostosis, and pachydermia. We have evaluated biochemical bone…”
    Get full text
    Journal Article
  12. 12

    Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone by RENDINA, D, POSTIGLIONE, L, VUOTTO, P, NUMIS, F. G, DI DOMENICO, G, VICECONTI, R, MOSSETTI, G, NUNZIATA, V

    Published in Clinical and experimental rheumatology (01-05-2002)
    “…Interleukin-6 (IL-6) and its soluble receptor (sIL-6R) stimulate osteoclast formation and activity. The primary cell abnormality in Paget's disease of bone…”
    Get full text
    Journal Article
  13. 13

    Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis by Rendina, D., De Filippo, G., Viceconti, R., Soscia, E., Sirignano, C., Salvatore, M., Della Monica, M., Scarano, G., Mossetti, G.

    Published in Scandinavian Journal of Rheumatology (01-01-2008)
    “…Primary pachydermoperiostosis (PDP) is a rare syndrome, characterized by digital clubbing, periostosis, and pachydermia. We have evaluated biochemical bone…”
    Get full text
    Report
  14. 14

    Development of a software for the design of custom-made hip prostheses using an open-source rapid application development environment by Viceconti, D. Testi, R. Gori, C. Zannoni, M.

    “…The present work describes a technology transfer project called HIPCOM devoted to the re-engineering of the process used by a medical devices manufacturer to…”
    Get full text
    Journal Article